InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
7
T+90 hit rate
0%
T+90 mean return
-50.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Schoenberg Mark, Directeur Médical. Director active across 1 company, notably UroGen Pharma Ltd.. In total, 28 reports have been recorded. Split: 1 buy · 7 sells. Total volume traded: €3.4m. History available since 18 November 2021. The latest transaction was disclosed on 20 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Schoenberg Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
60,677 shares@ US$47.050.12% mcap34.0% of flowordinary sharesSEC:0001437749-26-028840:0
10,000 shares@ US$40.000.017% mcap19.0% of flowOrdinary SharesSEC:0001437749-26-023290:0
1,844 shares@ US$19.691.7% of flowOrdinary SharesSEC:0001437749-26-003040:0
3,333 sharesOrdinary SharesSEC:0001437749-26-002843:0
10,000 shares@ US$25.0014.8% of flowOrdinary SharesSEC:0001437749-25-035821:0
1,667 sharesOrdinary SharesSEC:0001437749-25-028707:0
10,000 shares@ US$17.6912.3% of flowOrdinary SharesSEC:0001437749-25-026377:0
10,000 sharesOrdinary SharesSEC:0001437749-25-023961:0
10,000 sharesOrdinary SharesSEC:0001437749-25-020045:0
1,334 sharesOrdinary SharesSEC:0001437749-25-002688:0
1,666 sharesOrdinary SharesSEC:0001437749-24-029040:0
10,000 sharesOrdinary SharesSEC:0001437749-24-019900:0
12,000 shares@ US$14.0520.9% of flowOrdinary SharesSEC:0001437749-24-008707:0
1,137 shares@ US$15.782.2% of flowOrdinary SharesSEC:0001437749-24-003153:0
2,000 sharesOrdinary SharesSEC:0001437749-24-003016:0
500 sharesOrdinary SharesSEC:0001437749-23-002336:0
122,677 shares@ US$5.0076.4% of flowOrdinary SharesSEC:0001437749-23-001625:0
500 sharesOrdinary SharesSEC:0001437749-22-025549:0
500 sharesOrdinary SharesSEC:0001437749-22-021337:0
500 sharesOrdinary SharesSEC:0001437749-22-010701:0
500 sharesOrdinary SharesSEC:0001209191-22-006384:0
209 sharesOrdinary SharesSEC:0001209191-22-005416:0
160 shares@ US$13.100.1% of flowOrdinary SharesSEC:0001209191-21-065756:0
Canonical exit: 16 Feb 2022 (T+90)
500 sharesOrdinary SharesSEC:0001209191-21-062360:0
208 sharesOrdinary SharesSEC:0001209191-21-061868:0
25 of 28 declarations
About Schoenberg Mark
Mark Schoenberg is Director Médical and Chief Medical Officer at UroGen Pharma Ltd. He has 27 filings in total, and, in the sampled recent filings, the buy and sell amounts are EUR 1851 and EUR 920472, with filings ranging from 2021-05-04 to 2026-07-10. The most frequent transaction nature is Levée d'options.
